Literature DB >> 6331697

Acute effects of anti-arrhythmic drugs on cardiac pacing threshold.

J C Mohan, U Kaul, M L Bhatia.   

Abstract

Forty cardiac pacing threshold studies were conducted in 20 patients during temporary pacing prior to permanent pacemaker implantation using the following intravenously administered anti-arrhythmic drugs: Lignocaine 2 mg/kg (10 patients), mexiletine 5 mg/kg (5 patients), ajmaline 1 mg/kg (5 patients), verapamil 0.15 mg/kg (10 patients) and propranolol 0.1 mg/kg (10 patients). Changes in voltage (volts), current (mA), energy (micro-joules) and resistance (ohms), were measured using a pacemaker system analyzer at a constant pulse width (0.6 msec) and pacing rate (70/minute). Lignocaine increased the voltage threshold significantly (p less than 0.05) with insignificant (p greater than 0.05) change in current, energy and resistance. Mexiletine and ajmaline significantly (p less than 0.01 and p less than 0.02) increased the voltage and current thresholds but did not change the energy level and resistance (p greater less 0.05). Verapamil caused a significant increase in the current and energy threshold (p less than 0.05), without changing the voltage threshold significantly (p greater than 0.05). The resistance values showed a consistently decreasing trend. Propranolol on the other hand did not affect any parameter significantly (p greater than 0.05). Anti-arrhythmic drugs appear to produce variable effects on different pacing threshold parameters. This has important clinical implications.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331697

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  2 in total

1.  Cardiac Arrest due to Failed Pacemaker Capture After Peripheral Nerve Blockade With Levobupivacaine: A Case Report.

Authors:  Asuka Kitajima; Takeshi Nakatomi; Yuji Otsuka; Masamitsu Sanui; Alan Kawarai Lefor
Journal:  A A Pract       Date:  2021-04-01

Review 2.  From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer's Disease.

Authors:  Jazmín Alarcón-Espósito; Michael Mallea; Julio Rodríguez-Lavado
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.